CerS2 Overexpression Enhances Palmitoyl‐ CoA –Induced Cytotoxicity and Alters Ceramide Species Composition in Breast Cancer Cells
Lipids · 2026-11 · 61 (6) · 721-737
DOI: 10.1002/lipd.70071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lipids, online erschienen am 06.07.2026. Verfasst von Senem Ece Üner und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gene and Cell Therapy, Faculty of Medicine, Akdeniz University, Antalya, Turkey. Hauptthemen laut MEDLINE: Sphingosine N-Acyltransferase, Ceramides, Breast Neoplasms, Membrane Proteins. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Akdeniz Üniversitesi, Türkiye Bilimsel ve Teknolojik Araştırma Kurumu.
Abstract (Originalsprache)
Sphingolipid metabolism, particularly the balance between pro‐apoptotic ceramide and pro‐survival sphingosine‐1‐phosphate (S1P), has been associated with breast cancer progression. The aim of the present study was to examine whether ceramide synthase 2 (CerS2) overexpression is associated with changes in increased palmitoyl‐CoA (PCA) based ceramide buildup and cell fate changes in MCF‐7 breast cancer cells, a hormone receptor–positive model. CERS2 plasmid transfected cells were treated with PCA and/or the CerS inhibitor, fumonisin B1 (FB1). Cell viability, the proliferation marker proliferating cell nuclear antigen (PCNA), apoptosis (TUNEL and cleaved caspase‐3), and sphingolipid profiles were evaluated. High‐dose PCA (100 μM) significantly reduced MTT signal and PCNA expression and increased apoptotic markers, with stronger effects in CerS2‐overexpressing cells. Across short‐ and longer‐term exposures, the response pattern was concentration‐ and time‐responsive but not uniformly monotonic. Lipidomic analysis revealed that PCA and CerS2 overexpression increased C16 ceramide and very‐long‐chain ceramides (C22–C24), respectively. FB1 decreased the level of ceramide, elevated S1P and partly counteracted PCA‐induced cytotoxicity. FB1 pre‐treatment which was applied sequentially restricted but did not eliminate apoptosis. These findings indicate that CerS2 overexpression reshapes the cellular response to substrate‐driven sphingolipid stress by altering acyl‐chain–specific ceramide composition and the balance between ceramide‐ and S1P‐associated signaling. Rather than reflecting isolated pathway effects, the results support a context‐dependent role for CerS2 in modulating apoptotic sensitivity in MCF‐7 breast cancer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gene and Cell Therapy, Faculty of Medicine, Akdeniz University, Antalya, Turkey.
- Department of Medical Biotechnology, Institute of Health Sciences, Akdeniz University, Antalya, Turkey.
- Department of Medical Biochemistry, Akdeniz University Faculty of Medicine, Antalya, Turkey.
ORCID-Profile: Senem Ece Üner, Bürke Çırçırlı, Mutay Aslan
Förderung
- Akdeniz Üniversitesi
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
Zitieren
APA
Üner, S. E., Çırçırlı, B., & Aslan, M. (2026). CerS2 Overexpression Enhances Palmitoyl‐ CoA –Induced Cytotoxicity and Alters Ceramide Species Composition in Breast Cancer Cells. Lipids, 61(6), 721-737. https://doi.org/10.1002/lipd.70071
Vancouver
Üner SE, Çırçırlı B, Aslan M. CerS2 Overexpression Enhances Palmitoyl‐ CoA –Induced Cytotoxicity and Alters Ceramide Species Composition in Breast Cancer Cells. Lipids. 2026;61(6):721-737. doi:10.1002/lipd.70071
BibTeX
@article{ner2026,
author = {Üner, Senem Ece and Çırçırlı, Bürke and Aslan, Mutay},
title = {CerS2 Overexpression Enhances Palmitoyl‐ CoA –Induced Cytotoxicity and Alters Ceramide Species Composition in Breast Cancer Cells},
journal = {Lipids},
year = {2026},
volume = {61},
number = {6},
pages = {721--737},
doi = {10.1002/lipd.70071}
}
EUVIMED